Loss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome

A. Kemal Topaloglu, Alejandro Lomniczi, Doris Kretzschmar, Gregory Dissen, L. Damla Kotan, Craig A. McArdle, A. Filiz Koc, Ben C. Hamel, Metin Guclu, Esra D. Papatya, Erdal Eren, Eda Mengen, Fatih Gurbuz, Mandy Cook, Juan M. Castellano, M. Burcu Kekil, Neslihan O. Mungan, Bilgin Yuksel, Sergio Ojeda

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Context: Gordon Holmes syndrome (GHS) is characterized by cerebellar ataxia/atrophy and normosmic hypogonadotropic hypogonadism (nHH). The underlying pathophysiology of this combined neurodegeneration and nHH remains unknown.

Objective: We aimed to provide insight into the disease mechanism in GHS.

Methods: We studied a cohort of 6 multiplex families with GHS through autozygosity mapping and whole-exome sequencing.

Results: We identified 6 patients from 3 independent families carrying loss-of-function mutations in PNPLA6, which encodes neuropathy target esterase (NTE), a lysophospholipase that maintains intracellular phospholipid homeostasis by converting lysophosphatidylcholine to glycerophosphocholine. Wild-type PNPLA6, but not PNPLA6 bearing these mutations, rescued a well-established Drosophila neurodegenerative phenotype caused by the absence of sws, the fly ortholog of mammalian PNPLA6. Inhibition of NTE activity in the LβT2 gonadotropecell line diminished LH response to GnRH by reducing GnRH-stimulated LH exocytosis, without affecting GnRH receptor signaling or LHβ synthesis.

Conclusion: These results suggest that NTE-dependent alteration of phospholipid homeostasis in GHS causes both neurodegeneration and impaired LH release from pituitary gonadotropes, leading to nHH.

Original languageEnglish (US)
Pages (from-to)E2067-E2075
JournalJournal of Clinical Endocrinology and Metabolism
Volume99
Issue number10
DOIs
StatePublished - Oct 1 2014

Fingerprint

Hypogonadism
Gonadotropin-Releasing Hormone
Mutation
Phospholipids
Bearings (structural)
Lysophospholipase
LHRH Receptors
Lysophosphatidylcholines
Homeostasis
Exome
Cerebellar Ataxia
Exocytosis
Diptera
Drosophila
Atrophy
Phenotype
neurotoxic esterase
Cerebellar Ataxia and Hypogonadotropic Hypogonadism

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Loss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome. / Topaloglu, A. Kemal; Lomniczi, Alejandro; Kretzschmar, Doris; Dissen, Gregory; Kotan, L. Damla; McArdle, Craig A.; Koc, A. Filiz; Hamel, Ben C.; Guclu, Metin; Papatya, Esra D.; Eren, Erdal; Mengen, Eda; Gurbuz, Fatih; Cook, Mandy; Castellano, Juan M.; Kekil, M. Burcu; Mungan, Neslihan O.; Yuksel, Bilgin; Ojeda, Sergio.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 99, No. 10, 01.10.2014, p. E2067-E2075.

Research output: Contribution to journalArticle

Topaloglu, AK, Lomniczi, A, Kretzschmar, D, Dissen, G, Kotan, LD, McArdle, CA, Koc, AF, Hamel, BC, Guclu, M, Papatya, ED, Eren, E, Mengen, E, Gurbuz, F, Cook, M, Castellano, JM, Kekil, MB, Mungan, NO, Yuksel, B & Ojeda, S 2014, 'Loss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome', Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 10, pp. E2067-E2075. https://doi.org/10.1210/jc.2014-1836
Topaloglu, A. Kemal ; Lomniczi, Alejandro ; Kretzschmar, Doris ; Dissen, Gregory ; Kotan, L. Damla ; McArdle, Craig A. ; Koc, A. Filiz ; Hamel, Ben C. ; Guclu, Metin ; Papatya, Esra D. ; Eren, Erdal ; Mengen, Eda ; Gurbuz, Fatih ; Cook, Mandy ; Castellano, Juan M. ; Kekil, M. Burcu ; Mungan, Neslihan O. ; Yuksel, Bilgin ; Ojeda, Sergio. / Loss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome. In: Journal of Clinical Endocrinology and Metabolism. 2014 ; Vol. 99, No. 10. pp. E2067-E2075.
@article{1c09c77c5af7495980c6be17a67c1477,
title = "Loss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome",
abstract = "Context: Gordon Holmes syndrome (GHS) is characterized by cerebellar ataxia/atrophy and normosmic hypogonadotropic hypogonadism (nHH). The underlying pathophysiology of this combined neurodegeneration and nHH remains unknown.Objective: We aimed to provide insight into the disease mechanism in GHS.Methods: We studied a cohort of 6 multiplex families with GHS through autozygosity mapping and whole-exome sequencing.Results: We identified 6 patients from 3 independent families carrying loss-of-function mutations in PNPLA6, which encodes neuropathy target esterase (NTE), a lysophospholipase that maintains intracellular phospholipid homeostasis by converting lysophosphatidylcholine to glycerophosphocholine. Wild-type PNPLA6, but not PNPLA6 bearing these mutations, rescued a well-established Drosophila neurodegenerative phenotype caused by the absence of sws, the fly ortholog of mammalian PNPLA6. Inhibition of NTE activity in the LβT2 gonadotropecell line diminished LH response to GnRH by reducing GnRH-stimulated LH exocytosis, without affecting GnRH receptor signaling or LHβ synthesis.Conclusion: These results suggest that NTE-dependent alteration of phospholipid homeostasis in GHS causes both neurodegeneration and impaired LH release from pituitary gonadotropes, leading to nHH.",
author = "Topaloglu, {A. Kemal} and Alejandro Lomniczi and Doris Kretzschmar and Gregory Dissen and Kotan, {L. Damla} and McArdle, {Craig A.} and Koc, {A. Filiz} and Hamel, {Ben C.} and Metin Guclu and Papatya, {Esra D.} and Erdal Eren and Eda Mengen and Fatih Gurbuz and Mandy Cook and Castellano, {Juan M.} and Kekil, {M. Burcu} and Mungan, {Neslihan O.} and Bilgin Yuksel and Sergio Ojeda",
year = "2014",
month = "10",
day = "1",
doi = "10.1210/jc.2014-1836",
language = "English (US)",
volume = "99",
pages = "E2067--E2075",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "10",

}

TY - JOUR

T1 - Loss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome

AU - Topaloglu, A. Kemal

AU - Lomniczi, Alejandro

AU - Kretzschmar, Doris

AU - Dissen, Gregory

AU - Kotan, L. Damla

AU - McArdle, Craig A.

AU - Koc, A. Filiz

AU - Hamel, Ben C.

AU - Guclu, Metin

AU - Papatya, Esra D.

AU - Eren, Erdal

AU - Mengen, Eda

AU - Gurbuz, Fatih

AU - Cook, Mandy

AU - Castellano, Juan M.

AU - Kekil, M. Burcu

AU - Mungan, Neslihan O.

AU - Yuksel, Bilgin

AU - Ojeda, Sergio

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Context: Gordon Holmes syndrome (GHS) is characterized by cerebellar ataxia/atrophy and normosmic hypogonadotropic hypogonadism (nHH). The underlying pathophysiology of this combined neurodegeneration and nHH remains unknown.Objective: We aimed to provide insight into the disease mechanism in GHS.Methods: We studied a cohort of 6 multiplex families with GHS through autozygosity mapping and whole-exome sequencing.Results: We identified 6 patients from 3 independent families carrying loss-of-function mutations in PNPLA6, which encodes neuropathy target esterase (NTE), a lysophospholipase that maintains intracellular phospholipid homeostasis by converting lysophosphatidylcholine to glycerophosphocholine. Wild-type PNPLA6, but not PNPLA6 bearing these mutations, rescued a well-established Drosophila neurodegenerative phenotype caused by the absence of sws, the fly ortholog of mammalian PNPLA6. Inhibition of NTE activity in the LβT2 gonadotropecell line diminished LH response to GnRH by reducing GnRH-stimulated LH exocytosis, without affecting GnRH receptor signaling or LHβ synthesis.Conclusion: These results suggest that NTE-dependent alteration of phospholipid homeostasis in GHS causes both neurodegeneration and impaired LH release from pituitary gonadotropes, leading to nHH.

AB - Context: Gordon Holmes syndrome (GHS) is characterized by cerebellar ataxia/atrophy and normosmic hypogonadotropic hypogonadism (nHH). The underlying pathophysiology of this combined neurodegeneration and nHH remains unknown.Objective: We aimed to provide insight into the disease mechanism in GHS.Methods: We studied a cohort of 6 multiplex families with GHS through autozygosity mapping and whole-exome sequencing.Results: We identified 6 patients from 3 independent families carrying loss-of-function mutations in PNPLA6, which encodes neuropathy target esterase (NTE), a lysophospholipase that maintains intracellular phospholipid homeostasis by converting lysophosphatidylcholine to glycerophosphocholine. Wild-type PNPLA6, but not PNPLA6 bearing these mutations, rescued a well-established Drosophila neurodegenerative phenotype caused by the absence of sws, the fly ortholog of mammalian PNPLA6. Inhibition of NTE activity in the LβT2 gonadotropecell line diminished LH response to GnRH by reducing GnRH-stimulated LH exocytosis, without affecting GnRH receptor signaling or LHβ synthesis.Conclusion: These results suggest that NTE-dependent alteration of phospholipid homeostasis in GHS causes both neurodegeneration and impaired LH release from pituitary gonadotropes, leading to nHH.

UR - http://www.scopus.com/inward/record.url?scp=84907612367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907612367&partnerID=8YFLogxK

U2 - 10.1210/jc.2014-1836

DO - 10.1210/jc.2014-1836

M3 - Article

C2 - 25033069

AN - SCOPUS:84907612367

VL - 99

SP - E2067-E2075

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 10

ER -